IGEG
Live / Registered — Registered (as of 07 Jun 2022)
What this means for you
Registered since 07 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90424617
- Registration number
- 6750023
- Mark type
- Stylized text
- Filed
- 29 Dec 2020
- Published for opposition
- 15 Feb 2022
- Registered
- 07 Jun 2022
- Attorney of record
- Susan Piascik Christoff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; anti-cancer drugs; anti-cancer preparations; anti-cancer preparations of plant origin; anti-cancer preparations of chemical origin; compounds for treating cancer; tumor suppressing agents; immunostimulants; medicine for the treatment of cancer; diagnostic reagents for medical laboratory use
- Class 042 — Scientific and technological services: Development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; research and development of pharmaceuticals in the fields of oncology, immunology and immuno-oncology; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies; research and development in the field of recombinant proteins and antibodies for therapeutic and prophylactic use; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new therapeutic proteins and antibodies; development of pharmaceuticals, pharmaceutical ingredients, and antibodies; scientific study and research in the field of developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical services, namely, developing tumor targeting platform technologies; scientific research in the nature of scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the fields of oncology, immunology and immuno-oncology; pharmaceutical product development and evaluation services; pharmaceutical research and development; technical research in the field of pharmaceutical studies; conducting early evaluations in the field of new pharmaceuticals; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services in the fields of biotechnology and pharmaceutical research; consulting services for others in the field of design, planning, and implementation of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: Medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of cancerous diseases; pharmaceutical advisory services; medical laboratory analysis services relating to the treatment of persons; medical laboratory analysis services relating to the diagnosis and treatment of cancerous diseases; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-line information relating to oncology, immunology and immuno-oncology
- Class 045 — Legal and security services: Licensing of intellectual property rights; licensing of industrial property rights
Owner
- Epsilogen Ltd, London, GB
- Epsilogen Ltd, London, GB
- Epsilogen Ltd, London, GB
Prosecution history
- 07 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 29 Apr 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 01 Apr 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 15 Feb 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Feb 2022 — PUBLISHED FOR OPPOSITION
- 26 Jan 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jan 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 10 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jan 2022 — EXAMINER'S AMENDMENT ENTERED
- 10 Jan 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Jan 2022 — EXAMINERS AMENDMENT E-MAILED
- 10 Jan 2022 — EXAMINERS AMENDMENT -WRITTEN
- 28 Dec 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Dec 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE